The Fed, ETFs, Supply Chain, and Eli Lilly
Bloomberg Intelligence
00:00
The Role of Antibodies in Alzheimer's Disease
Two drugs that lower plaques have been able to produce some efficacy. Lily's drug is called Don nanomab. And biogen's drug is adducanumab. These things begin to form in brains. Not everybody who dies and has a brain looked at and it's got plaques actually got Alzheimer's. That's one of the problems. Only some people do. We need to push that boundary, that bar higher and higher and higher.
Play episode from 48:59
Transcript
